Ana Rovira - Concepedia

Author

Ana Rovira

Also Known As

A Rovira, A. M. ROVIRA, A. ML Rovira, A. Rovira, ANNA M. ROVIRA, Alex Rovira, Ana M. Rovira, Ana Maria Rovira, Ana Rovira, Anna M. Rovira

377

Publications

6.7K

Citations

H-Index

119

Concepts

All Affiliations

Hospital Del Mar Universitat Pompeu Fabra Municipal Institute for Medical Research Hospital Universitario Fundación Jiménez Díaz Universitat de Barcelona

About

Ana Rovira is an author at Hospital Del Mar specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	32	2.2K
2	Natural Sciences	12	12	372
3	Engineering	8	8	472
4	Health Sciences	1	1	11
5	Public Health	1	1	21

Ana Rovira

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations David Tamborero, Carlota Rubio-Pérez, Jordi Deu-Pons, Genome Medicine	2018	534
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer Clara Montagut, Alba Dalmases, Beatríz Bellosillo, Nature Medicine Extracellular DomainMedicineColorectal CancerCancer GenomicsCetuximab Resistance	2012	497
Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer Sabrina Arena, Beatríz Bellosillo, Giulia Siravegna, Clinical Cancer Research	2015	266
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer Federico Rojo, Jetzabel García-Parra, Sandra Zazo, Annals of Oncology Breast OncologyPoor Overall SurvivalEarly Breast CancerMedicineBreast Cancer	2011	177
Interleukin 6, a Nuclear Factor-κB Target, Predicts Resistance to Docetaxel in Hormone-Independent Prostate Cancer and Nuclear Factor-κB Inhibition by PS-1145 Enhances Docetaxel Antitumor Activity Josep Domingo‐Domenech, Cristina Oliva, Ana Rovira, Clinical Cancer Research	2006	169
Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer Marta Salido, Lara Pijuán, Luz Martínez‐Avilés, Journal of Thoracic Oncology Tumor BiologyOncologyMedicinePathologyCancer Genomics	2010	158
A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples Anna Esteve‐Codina, Oriol Arpí, Maria Martinez‐García, PLoS ONE EngineeringPathologyTranscriptomics TechnologyHigh-grade GliomasGlioma	2017	145
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses Clara Montagut, Guillem Argilés, Fortunato Ciardiello, JAMA Oncology	2018	142
Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer Israel Cañadas, Federico Rojo, Álvaro Taus, Clinical Cancer Research	2013	135
NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival Aura Muntasell, Federico Rojo, Sònia Servitja, Clinical Cancer Research	2019	130

Page 1